Enjoy complimentary customisation on priority with our Enterprise License!
The global epinephrine autoinjector market size is estimated to grow by USD 2.44 billion at a CAGR of 10.59% between 2023 and 2028.
The companies operating in the market have been implementing different strategies to expand their product portfolio, especially over the last five years, which have significantly impacted the global epinephrine autoinjector market. They are undergoing different business strategies, such as M&A and technology partnerships, to increase their market presence and the sales of their product range. ALK Abello conducts clinical trials in order to prove Jext's efficacy equivalent to Viatriss EpiPen. Before Auvi-Q and Allerjects complete recall from the market, Sanofi engaged in various marketing strategies to increase its market share. Thus, companies are adopting various strategies to encourage end-users to use epinephrine autoinjectors, which will nullify the adverse impact of the high cost of these products. Such innovation and strategies for marketing by the companies will drive the growth of the market during the forecast period.
Technavio has segmented the market into Type, End-user, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.